Leveraging Emerging Science to Improve Patient Outcomes and Streamline Workflow

A new scientific study, led by Dr. Niraj Varma and conducted by a team of leading experts, has cemented the importance of remote cardiac monitoring for Cardiac Implantable Electronic Devices (CIEDs).

Published in Europace 2023, the paper “Remote monitoring of cardiac implantable electronic devices and disease management” outlines the remarkable benefits in clinical efficiency and patient safety, offering illuminating insights that underscore the value proposition of Implicity’s remote cardiac monitoring platforms.

Dynamic and Tailored Patient Treatment Pathways

The study underlines the transformative impact of remote monitoring in facilitating personalized, dynamic treatment pathways. This is particularly beneficial for assessing the success rates of Atrial Fibrillation (AF) therapies, a capability that resonates with Implicity’s mission to improve patient outcomes. Our AF Alert Management Algorithm, a CE-marked tool, works seamlessly with the device data and clinical information to offer tailored AF treatment.

Enhancements in AF Detection and Anticoagulation Treatment

The study impressively demonstrates that algorithms designed to scan all CIED transmissions for AF, enhanced AF detection sensitivity by 10%. In addition, these algorithms also improved the optimal treatment of oral anticoagulation by 6%. Implicity’s AF Alert Management Algorithm directly addresses these findings, focusing on analyzing device data like atrial burden raw data and clinical information such as anticoagulant medications. Our advanced algorithmic approach filters out irrelevant alerts while activating smart alerts for significant changes in AF treatment, streamlining anticoagulation treatment.

Efficient Alert Management and Workflow Optimization

An especially compelling point in the study is the application of an AI tool to filter AF alerts, resulting in an 84% reduction in notification burden without compromising patient safety. The work-saving benefit aligns closely with the capabilities of Implicity’s AF Alert Management Algorithm, which automates the labor-intensive process of AF monitoring. 

Assisting Resource-Strained Hospitals

The study suggests that third-party resources offer valuable support for healthcare institutions lacking the required staffing. Remote cardiac monitoring from Implicity extends your healthcare team and enables you to focus on critical cases by automating routine tasks.

The landscape of cardiac care is undergoing a profound transformation, as illustrated by the study’s conclusion, even though remote monitoring of CIEDs has been the standard of care since 2015. New guidelines suggest clinically stable patients may only require in-office visits every 24 months or less frequently, introducing vast implications for workflow, reimbursement, and data management.

The value of Implicity’s remote cardiac monitoring platforms extends beyond the technology’s robustness to the system’s adaptability and scalability. Drawing from the compelling evidence in this latest study, Implicity’s AF Alert Algorithm is a paragon of innovation optimized for efficiency and patient safety.

Written by: Megan Grosz

Read the Study


Niraj Varma, Frieder Braunschweig, Haran Burri, Gerhard Hindricks, Dominik Linz, Yoav Michowitz, Renato Pietro Ricci, and Jens Cosedis Nielsen. Remote monitoring of cardiac implantable electronic devices and disease management. Europace (2023) 25, 1–11 https://doi.org/10.1093/europace/euad233





Share This